Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
    Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology Australia, Germany, Israel, Italy, Spain, Switzerland
    PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
    Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine
    Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era
    Release Date:
    Review Process: Pfizer Internal
    Research Vaccines Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of
    The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China, Hong Kong
    COVID-19 Disease Burden on the High Risk Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines All
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Established Investigators
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Inflammatory and Immune-Mediated Dermatologic Disorders Research RFP: Early Career Investigators
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    2022 Rheumatology Competitive Grant Program
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology USA
    Innovative Digital Health Projects in Oncology
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    BRAF V600-mutant colorectal cancer: disease education and therapy management
    Release Date:
    Partner: Lilly
    Review Process: Pfizer Internal
    Education Oncology USA
    Quality Improvement Grants to Improve Identification and Management of Patients with ATTR-CM in Canada
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Quality Improvement Rare Disease Canada
    Heart Failure and Cardiomyopathy Leading to Differential Diagnoses of Cardiac Amyloidosis
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease Japan
    Establish a System to Refer Patients with Suspected Cardiomyopathy
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan
    Improving the care of patients living with metastatic breast cancer (mBC)
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Quality Improvement Oncology Canada
    Establishing Antimicrobial Stewardship (AMS) Centres of Excellence to Improve Patient Outcomes by Addressing Access Disparities
    Release Date:
    Partner: BSAC
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Promotion of Smoking Cessation Treatment in General Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Global ATTR Amyloidosis Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All